These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 35662442)

  • 41. Emerging pharmacotherapy for treatment of Graves' disease.
    Bahn RS
    Expert Rev Clin Pharmacol; 2012 Nov; 5(6):605-7. PubMed ID: 23234319
    [No Abstract]   [Full Text] [Related]  

  • 42. [Reflections on the therapeutic goal in Basedow hyperthyroidism].
    Höfer R
    Acta Med Austriaca; 1987; 14(3-4):70-2. PubMed ID: 2447737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study.
    Marcocci C; Bruno-Bossio G; Manetti L; Tanda ML; Miccoli P; Iacconi P; Bartolomei MP; Nardi M; Pinchera A; Bartalena L
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):503-8. PubMed ID: 10583319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology, management and outcomes of Graves' disease-real life data.
    Hussain YS; Hookham JC; Allahabadia A; Balasubramanian SP
    Endocrine; 2017 Jun; 56(3):568-578. PubMed ID: 28478488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperthyroidism.
    Lazarus JH
    Lancet; 1997 Feb; 349(9048):339-43. PubMed ID: 9024389
    [No Abstract]   [Full Text] [Related]  

  • 46. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
    Bahn Chair RS; Burch HB; Cooper DS; Garber JR; Greenlee MC; Klein I; Laurberg P; McDougall IR; Montori VM; Rivkees SA; Ross DS; Sosa JA; Stan MN; ;
    Thyroid; 2011 Jun; 21(6):593-646. PubMed ID: 21510801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Graves' disease.
    Weetman AP
    N Engl J Med; 2000 Oct; 343(17):1236-48. PubMed ID: 11071676
    [No Abstract]   [Full Text] [Related]  

  • 48. The relationship between thyroid eye disease and radioiodine treatment.
    Thou S; Vinjamuri S
    Nucl Med Commun; 2019 Mar; 40(3):194-198. PubMed ID: 30614922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
    Chen DY; Chen TH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of hyperthyroidism.
    McClung MR; Greer MA
    Annu Rev Med; 1980; 31():385-404. PubMed ID: 6156639
    [No Abstract]   [Full Text] [Related]  

  • 51. Controversies in the pharmacological treatment of Graves' disease in children.
    De Luca F; Valenzise M
    Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1113-1121. PubMed ID: 30417713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of radical treatment of Basedow's disease on the ocular symptoms].
    Lederer J
    Ann Endocrinol (Paris); 1974; 35(1):79-81. PubMed ID: 4138226
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation and Management of Children with Thyrotoxicosis.
    Leung AKC; Leung AAC
    Recent Pat Endocr Metab Immune Drug Discov; 2017; 11(1):22-31. PubMed ID: 29589552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pregnancy and the thyroid gland].
    Lieutaud H
    Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thyroid eye disease for the primary care physician.
    Phelps PO; Williams K
    Dis Mon; 2014 Jun; 60(6):292-8. PubMed ID: 24906675
    [No Abstract]   [Full Text] [Related]  

  • 56. Current controversies in the management of Graves' hyperthyroidism.
    Francis N; Francis T; Lazarus JH; Okosieme OE
    Expert Rev Endocrinol Metab; 2020 May; 15(3):159-169. PubMed ID: 32315207
    [No Abstract]   [Full Text] [Related]  

  • 57. Current treatment of Graves' disease.
    Harada T; Shimaoka K; Mimura T; Ito K
    Surg Clin North Am; 1987 Apr; 67(2):299-314. PubMed ID: 2436323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between radioiodine therapy for Graves' hyperthyroidism and thyroid-associated ophthalmopathy.
    El-Kaissi S; Bowden J; Henry MJ; Yeo M; Champion BL; Brotchie P; Nicholson GC; Wall JR
    Int Ophthalmol; 2010 Aug; 30(4):397-405. PubMed ID: 20405165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Indication and contraindication of radioiodine therapy for Graves' disease].
    Misaki T
    Nihon Rinsho; 2012 Nov; 70(11):1922-6. PubMed ID: 23214062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
    Chen DY; Schneider PF; Zhang XS; Luo XY; He ZM; Chen TH
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):1-6. PubMed ID: 24203649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.